Ghent Research Group on Nanomedicines
The Laboratory of General Biochemistry and Physical Pharmacy hosts the Ghent Research Group on Nanomedicines (GRGN). Nanomedicines aims at applying nanotechnology in drug therapy and medical diagnostics. Advanced drug delivery and medical diagnostics constitute the core disciplines of GRCN. Advanced drug delivery systems are nano-/micrometre sized delivery systems for biological therapeutic agents (like nucleic acids and proteins) which are much larger than classical drugs like for example aspirin. The GRGN is a multidisciplinary research environment, including pharmacists, material engineers, cellular biologists and biophysics who build scientific and technical expertise between "nano" and pharmacy. Most of the research projects of the GRGN are carried out in collaboration with European laboratories. The GRGN is a member of BRAINSTIM, a Belgian research consortium on stem cell research. The GRGN takes on the EU funded projects MEDITRANS (on targeted drug delivery), ARISE (on drug delivery to the brain after stroke) and SONODRUGS (which evaluates the potential of ultrasound energy to deliver drugs to cancer tissues).